Scholarly Index
Michael R. Bristow
University of Colorado Anschutz Medical Campus; 55,881 total citations; 512 total publications; best world rank #14
University of Colorado Anschutz Medical Campus
55,881Total citations
512Total publications
107H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Cardiac electrophysiology and arrhythmias | Lifetime | 57 | US 30 | 99.74 |
| Receptor Mechanisms and Signaling | Lifetime | 58 | US 38 | 99.74 |
| Pharmacological Effects and Assays | Lifetime | 14 | US 9 | 99.54 |
| Chemotherapy-induced cardiotoxicity and mitigation | Lifetime | 16 | US 10 | 99.24 |
| Heart Failure Treatment and Management | Lifetime | 60 | US 37 | 99.76 |
| Cardiovascular Function and Risk Factors | Lifetime | 173 | US 112 | 99.64 |
| Cardiomyopathy and Myosin Studies | Lifetime | 114 | US 66 | 99.09 |
| Cardiac pacing and defibrillation studies | Lifetime | 179 | US 102 | 99.38 |
| Transplantation: Methods and Outcomes | Lifetime | 243 | US 153 | 98.56 |
| Viral Infections and Immunology Research | Lifetime | 307 | US 159 | 98.20 |
| Cardiac Ischemia and Reperfusion | Lifetime | 223 | US 117 | 98.39 |
| Pulmonary Hypertension Research and Treatments | Lifetime | 698 | US 333 | 96.89 |
| Signaling Pathways in Disease | Lifetime | 399 | US 208 | 95.94 |
| Cardiac Fibrosis and Remodeling | Lifetime | 556 | US 202 | 93.34 |
| Chemotherapy-related skin toxicity | Lifetime | 411 | US 202 | 88.71 |
| Heart rate and cardiovascular health | Lifetime | 867 | US 241 | 63.87 |